Medicare

Treatments that can slow the disease in some patients have recently become more widely available, but not everyone can benefit.

Software sifts through millions of medical records to match patients with similar diagnoses and characteristics and predicts what kind of care an individual will need. New rules will ensure humans are part of the process.

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

Elizabeth Hernandez, 45, routinely billed more than 24 hours of “office visits” in a day and pocketed about $1.6 million, federal prosecutors said.

Before COVID, hepatitis C held the distinction of claiming more American lives each year than any other infectious disease — that’s despite the marketing of several relatively affordable, highly effective treatments.

For the first time, Medicare will negotiate the prices of 10 common medicines. Dr. Meena Seshamani, with the Center for Medicare at CMS, and Brian Brito, VP of pharmacy at CareMax, talk about the process.

The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?

The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drug-makers are fighting the negotiations with lawsuits.

The federal government is proposing having Medicare pay professionals to train family caregivers how to perform tasks like bathing and dressing their loved ones, and properly use medical equipment.

A new report by AARP found that the top 25 drugs — covered under Medicare Part D — have almost tripled in price since they first entered the market.